We’ll be at the BAD Annual Meeting in Glasgow

by H Ali | May 29, 2025 | News

BADBIR Participants Using the Patient Portal Your data Participant FAQs Patient Newsletters Clinicians Eligibility Study information Conducting BADBIR remotely Associate Principal Investigator Scheme Centre Report Average daily dose Participating centres Steering...

Changes to conventional cohort eligibility criteria

by H Ali | May 8, 2025 | News

BADBIR Participants Using the Patient Portal Your data Participant FAQs Patient Newsletters Clinicians Eligibility Study information Conducting BADBIR remotely Associate Principal Investigator Scheme Centre Report Average daily dose Participating centres Steering...

Amendment 14

by H Ali | Apr 8, 2025 | Amendments

BADBIR Participants Using the Patient Portal Your data Participant FAQs Patient Newsletters Clinicians Eligibility Study information Conducting BADBIR remotely Associate Principal Investigator Scheme Centre Report Average daily dose Participating centres Steering...

Age and biologic survival in patients with ​moderate-to-severe psoriasis: a cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR)

by H Ali | Jan 10, 2025 | Publications

BADBIR Participants Using the Patient Portal Your data Participant FAQs Patient Newsletters Clinicians Eligibility Study information Conducting BADBIR remotely Associate Principal Investigator Scheme Centre Report Average daily dose Participating centres Steering...

Taltz (ixekizumab) recruitment has restarted

by H Ali | Dec 12, 2024 | News

BADBIR Participants Using the Patient Portal Your data Participant FAQs Patient Newsletters Clinicians Eligibility Study information Conducting BADBIR remotely Associate Principal Investigator Scheme Centre Report Average daily dose Participating centres Steering...